201 related articles for article (PubMed ID: 18445140)
1. A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations.
Gennari M; Stratakis CA; Hovarth A; Pirazzoli P; Cicognani A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):751-5. PubMed ID: 18445140
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies of novel PRKAR1A mutants that extend the predicted RIα protein sequence into the 3'-untranslated open reading frame: proteasomal degradation leads to RIα haploinsufficiency and Carney complex.
Patronas Y; Horvath A; Greene E; Tsang K; Bimpaki E; Haran M; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Mar; 97(3):E496-502. PubMed ID: 22205709
[TBL] [Abstract][Full Text] [Related]
3. A novel splice site mutation of the PRKAR1A gene, C.440+5 G>C, in a Chinese family with Carney complex.
Fu J; Lai F; Chen Y; Wan X; Wei G; Li Y; Xiao H; Cao X
J Endocrinol Invest; 2018 Aug; 41(8):909-917. PubMed ID: 29318463
[TBL] [Abstract][Full Text] [Related]
4. A Novel Inherited Mutation in PRKAR1A Abrogates PreRNA Splicing in a Carney Complex Family.
Sun Y; Chen X; Sun J; Wen X; Liu X; Zhang Y; Hoffman AR; Hu JF; Gao Y
Can J Cardiol; 2015 Nov; 31(11):1393-401. PubMed ID: 26416542
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
Stratakis CA
Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
[TBL] [Abstract][Full Text] [Related]
6. Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation.
Storr HL; Metherell LA; Dias R; Savage MO; Rasmussen AK; Clark AJ; Main KM
Horm Res Paediatr; 2010; 73(2):115-9. PubMed ID: 20190548
[TBL] [Abstract][Full Text] [Related]
7. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.
Groussin L; Horvath A; Jullian E; Boikos S; Rene-Corail F; Lefebvre H; Cephise-Velayoudom FL; Vantyghem MC; Chanson P; Conte-Devolx B; Lucas M; Gentil A; Malchoff CD; Tissier F; Carney JA; Bertagna X; Stratakis CA; Bertherat J
J Clin Endocrinol Metab; 2006 May; 91(5):1943-9. PubMed ID: 16464939
[TBL] [Abstract][Full Text] [Related]
8. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
Anselmo J; Medeiros S; Carneiro V; Greene E; Levy I; Nesterova M; Lyssikatos C; Horvath A; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2012 Feb; 97(2):351-9. PubMed ID: 22112814
[TBL] [Abstract][Full Text] [Related]
9. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.
Pereira AM; Hes FJ; Horvath A; Woortman S; Greene E; Bimpaki E; Alatsatianos A; Boikos S; Smit JW; Romijn JA; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2010 Jan; 95(1):338-42. PubMed ID: 19915019
[TBL] [Abstract][Full Text] [Related]
10. Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing.
Salpea P; Horvath A; London E; Faucz FR; Vetro A; Levy I; Gourgari E; Dauber A; Holm IA; Morrison PJ; Keil MF; Lyssikatos C; Smith ED; Sanidad MA; Kelly JC; Dai Z; Mowrey P; Forlino A; Zuffardi O; Stratakis CA
J Clin Endocrinol Metab; 2014 Jan; 99(1):E183-8. PubMed ID: 24170103
[TBL] [Abstract][Full Text] [Related]
11. A Novel Missense PRKAR1A Variant Causes Carney Complex.
Kim B; Jang HN; Chae KS; Shin HS; Kim YH; Kim SJ; Seong MW; Kim JH
Endocrinol Metab (Seoul); 2022 Oct; 37(5):810-815. PubMed ID: 36193716
[TBL] [Abstract][Full Text] [Related]
12. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
Bertherat J; Horvath A; Groussin L; Grabar S; Boikos S; Cazabat L; Libe R; René-Corail F; Stergiopoulos S; Bourdeau I; Bei T; Clauser E; Calender A; Kirschner LS; Bertagna X; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2009 Jun; 94(6):2085-91. PubMed ID: 19293268
[TBL] [Abstract][Full Text] [Related]
13. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
14. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.
Horvath A; Bertherat J; Groussin L; Guillaud-Bataille M; Tsang K; Cazabat L; Libé R; Remmers E; René-Corail F; Faucz FR; Clauser E; Calender A; Bertagna X; Carney JA; Stratakis CA
Hum Mutat; 2010 Apr; 31(4):369-79. PubMed ID: 20358582
[TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.
Kirschner LS; Sandrini F; Monbo J; Lin JP; Carney JA; Stratakis CA
Hum Mol Genet; 2000 Dec; 9(20):3037-46. PubMed ID: 11115848
[TBL] [Abstract][Full Text] [Related]
16. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
Graham RP; Lackner C; Terracciano L; González-Cantú Y; Maleszewski JJ; Greipp PT; Simon SM; Torbenson MS
Hepatology; 2018 Oct; 68(4):1441-1447. PubMed ID: 29222914
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel mutation of the PRKAR1A gene in a patient with Carney complex with significant osteoporosis and recurrent fractures.
Papanastasiou L; Fountoulakis S; Voulgaris N; Kounadi T; Choreftaki T; Kostopoulou A; Zografos G; Lyssikatos C; Stratakis CA; Piaditis G
Hormones (Athens); 2016; 15(1):129-35. PubMed ID: 27377598
[TBL] [Abstract][Full Text] [Related]
18. A novel PRKAR1A mutation in Korean Carney complex family.
Rhee SY; Kwon HS; Lee JH; Woo JT; Kim MK; Lim YJ; Rhee BA; Koh SH; Lee S; Lee MH; Kim DY; Chon S; Oh S; Kim SW; Kim JW; Kim YS; Choi YK
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):7-13. PubMed ID: 22020668
[TBL] [Abstract][Full Text] [Related]
19. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
Libé R; Horvath A; Vezzosi D; Fratticci A; Coste J; Perlemoine K; Ragazzon B; Guillaud-Bataille M; Groussin L; Clauser E; Raffin-Sanson ML; Siegel J; Moran J; Drori-Herishanu L; Faucz FR; Lodish M; Nesterova M; Bertagna X; Bertherat J; Stratakis CA
J Clin Endocrinol Metab; 2011 Jan; 96(1):E208-14. PubMed ID: 21047926
[TBL] [Abstract][Full Text] [Related]
20. PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors.
Maleszewski JJ; Larsen BT; Kip NS; Castonguay MC; Edwards WD; Carney JA; Kipp BR
Am J Surg Pathol; 2014 Aug; 38(8):1079-87. PubMed ID: 24618615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]